Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas

NCT00785798 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped sponsor requested

Conditions

Relapsed Lymphomas
Refractory Lymphomas

Interventions

DRUG: Vorinostat
DRUG: Pegylated Liposomal Doxorubicin (PLD), Doxil

Sponsor

Yale University

Collaborators

[object Object]